# Hester Biosciences Ltd (HESTERBIO)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹1881.9
Day Change: +2.33%
52W High: ₹2347.7
52W Low: ₹1250.95
Market Cap: ₹1,560 Cr

## Valuation
P/E: 37.88
P/B: 4.65
EPS: ₹48.42
Book Value: ₹394.06
Dividend Yield: 0%

## Returns
1Y Return: 5.77%

## Profitability
ROE: 0%
ROCE: 9.98%
Debt/Equity: 0.61
Revenue Growth: 9%
Profit Growth: -18.4%
EBITDA Margin: 22.74%
Operating Margin: 17.26%

## About
Hester Biosciences Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Hester Biosciences Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Investor Presentation: Announcement Under Regulation 30 (LODR) - Corporate Presentation
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- BSE Filing: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:02.224Z
Price History Updated: 2026-05-18T22:59:00.589Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:59:00.589Z
Quant Updated: 2026-05-18T22:59:00.589Z
Sentiment Updated: 2026-05-18T22:59:00.589Z
Financials Status: current
Financials Updated: 2026-05-18T17:32:10.546Z
Financials Last Attempt: 2026-05-18T17:32:10.546Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2015)
Revenue: ₹69 Cr
Operating Profit: ₹24 Cr (OPM 36%)
Net Profit: ₹9 Cr
Tax: ₹13 Cr

## Annual P&L History
Mar 2015: Rev ₹69Cr | PAT ₹9Cr | OPM 36%
Mar 2016: Rev ₹90Cr | PAT ₹13Cr | OPM 28%
Mar 2017: Rev ₹101Cr | PAT ₹19Cr | OPM 34%

## Balance Sheet (Mar 2015)
Total Assets: ₹142 Cr
Total Liabilities: ₹142 Cr
Borrowings: ₹48 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Rajiv Dinesh Gandhi B.Com, Executive CEO, MD & Executive Director
- Priya Rajiv Gandhi, Executive Director
- Ashish Dineshbhai Desai, Chief Financial Officer
- Vinod  Mali, Company Secretary & Compliance Officer
- Sulochana  Shrestha, CEO of Hester Biosciences Nepal Private Limited

---
Source: rupiya.io/stocks/hesterbio
Disclaimer: For research and education only. Not investment advice.